Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
Blumenthal, Deborah T; Gorlia, Thierry; Gilbert, Mark R; Kim, Michelle M; Burt Nabors, L; Mason, Warren P; Hegi, Monika E; Zhang, Peixin; Golfinopoulos, Vassilis; Perry, James R; Hyun Nam, Do; Erridge, Sara C; Corn, Benjamin W; Mirimanoff, René O; Brown, Paul D; Baumert, Brigitta G; Mehta, Minesh P; van den Bent, Martin J; Reardon, David A; Weller, Michael; Stupp, Roger (2017). Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG. Neuro-Oncology, 19(8):1119-1126.
Additional indexing
Item Type: | Journal Article, refereed, original work |
---|---|
Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology |
Dewey Decimal Classification: | 610 Medicine & health |
Scopus Subject Areas: | Health Sciences > Oncology
Health Sciences > Neurology (clinical) Life Sciences > Cancer Research |
Language: | English |
Date: | 1 August 2017 |
Deposited On: | 09 Nov 2017 07:26 |
Last Modified: | 19 Aug 2024 03:43 |
Publisher: | Oxford University Press |
ISSN: | 1522-8517 |
OA Status: | Closed |
Free access at: | Publisher DOI. An embargo period may apply. |
Publisher DOI: | https://doi.org/10.1093/neuonc/nox025 |
PubMed ID: | 28371907 |
Permanent URL
https://doi.org/10.5167/uzh-141038Download
Links
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
0 downloads since deposited on 09 Nov 2017
0 downloads since 12 months
0 downloads since 12 months